Skip to main content
ORGANOIDSCIENCES LTD. logo

ORGANOIDSCIENCES LTD. — Investor Relations & Filings

Ticker · 476040 ISIN · KR7476040001 KO Professional, scientific and technical activities
Open in API
Filings indexed 53 across all filing types
Latest filing 2025-05-16 Major Shareholding Noti…
Country KR South Korea
Listing KO 476040

About ORGANOIDSCIENCES LTD.

https://organoidrx.com/en/

ORGANOIDSCIENCES LTD. is a biotechnology company specializing in organoid-based technologies for drug development and regenerative medicine. The company develops next-generation cell therapies and treatments for incurable diseases by creating three-dimensional cell cultures that replicate the structure and function of human organs. Its core offerings include an Organoid-Based Regenerative Therapeutics Platform to overcome the limitations of conventional therapies and an evaluation platform for assessing drug efficacy and toxicity, providing an alternative to animal models. Additionally, the company has developed the Polaris Platform for evaluating immunotherapy sensitivity. ORGANOIDSCIENCES aims to provide innovative solutions for precise and proactive care, shifting the paradigm in the therapeutics market.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the acquisition of shares in 'Organoid Sciences' by 'Aju IB Investment' and its related funds. This type of filing is specifically used to notify the market when a shareholder crosses a significant ownership threshold (typically 5%). In the provided taxonomy, this corresponds to a Major Shareholding Notification.
2025-05-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the acquisition and disposal of shares by a major shareholder (Company K Partners) in a listed company (Organoid Sciences). This falls under the category of Major Shareholding Notification.
2025-05-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the acquisition and disposal of shares by Atinum Investment in Organoid Sciences. Since this document specifically reports changes in significant share ownership levels (crossing thresholds or initial reporting upon listing), it falls under the 'Major Shareholding Notification' category.
2025-05-16 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details the shareholding changes of LB Investment Inc. in Organoid Sciences. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema, as it tracks changes in significant ownership levels.
2025-05-16 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as the 5% rule filing). It details the share ownership of major shareholders and special related parties of Organoid Sciences Co., Ltd. following its KOSDAQ listing. This falls under the category of Major Shareholding Notification.
2025-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a Korean regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard disclosure form required by the Financial Supervisory Service (FSS) in South Korea when an insider (executive or major shareholder) changes their shareholding position. This falls under the category of Director's Dealing (DIRS), which covers insider transactions and ownership reports.
2025-05-15 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.